Literature DB >> 8421678

Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene.

D Zafriri1, M Argaman, E Canaani, A Kimchi.   

Abstract

Interleukin 6 (IL-6) induces in M1 myeloblastic cells growth arrest and terminal differentiation toward monocytes. It is reported here that IL-6 reduced by 5- to 20-fold the tyrosine phosphorylation of cellular proteins in these cells. The same-fold reduction was also observed in M1 cells that were transfected with the BCR-ABL deregulated protein kinase. In these stable clones, the levels of tyrosine phosphorylation of cellular proteins were 30- to 100-fold higher than in the parental cells. IL-6 did not reduce the expression levels or the inherent tyrosine kinase activity of BCR-ABL p210. By measuring the protein-tyrosine-phosphatase (PTPase; protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) activity in crude cell lysates, we found that protein dephosphorylation resulted, at least partially, from induction of PTPase activity by IL-6. The induction of PTPase in the BCR-ABL-transfected clones was not sufficient to confer the minimal protein phosphorylation levels characteristic of IL-6-treated cells. Yet, the transfected M1 clones showed normal growth and differentiation responses to IL-6. None of the gene responses to IL-6 including suppression in the levels of c-myc, c-myb, and cyclin A mRNA; junB and c-jun mRNA induction; and dephosphorylation of retinoblastoma protein were rescued by the BCR-ABL oncogene. The functional relevance of PTPase induction by IL-6 is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421678      PMCID: PMC45686          DOI: 10.1073/pnas.90.2.477

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis.

Authors:  A Kimchi; D Resnitzky; R Ber; G Gat
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

2.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

Review 3.  Activation of the abl oncogene in murine and human leukemias.

Authors:  J B Konopka; O N Witte
Journal:  Biochim Biophys Acta       Date:  1985-11-12

4.  Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Authors:  G Q Daley; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.

Authors:  K Shibata; J Nishimura; H Takahira; H Nawata
Journal:  Leukemia       Date:  1989-09       Impact factor: 11.528

6.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

7.  The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6.

Authors:  Y Shabo; J Lotem; M Rubinstein; M Revel; S C Clark; S F Wolf; R Kamen; L Sachs
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

8.  Induction of protooncogene c-jun by serum growth factors.

Authors:  K Ryder; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia.

Authors:  I K Hariharan; J M Adams; S Cory
Journal:  Oncogene Res       Date:  1988

10.  Characterization of junD: a new member of the jun proto-oncogene family.

Authors:  S I Hirai; R P Ryseck; F Mechta; R Bravo; M Yaniv
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  2 in total

1.  Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

Authors:  S M Hernández-Sotomayor; C L Arteaga; C Soler; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

2.  A factor induced by differentiation signals in cells of the macrophage lineage binds to the gamma interferon activation site.

Authors:  A Eilers; M Baccarini; F Horn; R A Hipskind; C Schindler; T Decker
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.